Central African Republic vs Syria: The number of people with susceptibility test result for rifampicin
Central African Republic
660
in 2021
Syria
705
in 2021
Central African Republic rank
73rd
Syria rank
71st
The number of people with susceptibility test result for rifampicin over time
- Central African Republic
- Syria
How they compare
Syria currently reports 705 against 660 in Central African Republic, a difference of 45.
That makes Syria's figure about 1.1 times Central African Republic's.
Across all 5 years both countries report, Syria has been ahead every year.
Central African Republic ranks 73rd and Syria ranks 71st of 155 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 101.67 | 491.33 | 389.67 | Syria |
| 2020s | 665.5 | 808.5 | 143 | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Syria?
- Syria, at 705 against 660 in Central African Republic as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Syria?
- 45, with Syria ahead.
- How many years of comparable data are there for Central African Republic and Syria?
- 5 years are reported by both, from 2017 to 2021.
- How do Central African Republic and Syria rank globally for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 73rd and Syria ranks 71st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.